Company: PFSA
Filing Date: 2025-05-13
Form Type: S-4/A
Source: 0001213900-25-042224
Chunk: 271

Company: Profusa, Inc.
Filing Date: 2025-05-13
Form: S-4/A
Chunk 271
---
 subject to trading conditions and subject to investment committee approval; •3 rdtranche $10 million, subject to trading conditions and subject to investment committee approval; and •4 thtranche $10 million, subject to trading conditions and subject to investment committee approval. Redemption Recapture Agreement key term: •Up to 5 million share ($50 million) On May 15, 2023, Atalaya, Profusa and Northview signed an NDA and on May 17, 2023 the parties had a Zoom call to discuss the draft term sheets. 132 On May 25, 2023, NorthView and Profusa responded to the draft term sheet via a marked up version of the draft term sheet. Key term changes to the Senior Convertible Note were as follows: •$26 million (an up to $100 million) secured Convertible Notes with 1.3 million detachable warrants (struck at 135% of the Note conversion price) and 7% OID to be funded over multiple tranches at % interest; •1 sttranche $3 million of funding at the Closing of the Merger, less OID; •2 ndtranche $3 million, upon registration of the underlying shares; •3 rdtranche $10 million, subject to trading conditions and subject to investment committee approval; and •4 thtranche $10 million, subject to trading conditions and subject to investment committee approval. On June 2, 2023, Atalaya responded to NorthView and Profusa’s counteroffer and essentially reverted back to their original proposal and on June 20, 2024 the parties executed non -bindingterm sheets for the Senior Convertible Note and Redemption Capture agreement. The Senior Convertible Note key terms included: •$26 million (an up to $100 million) secured Convertible Notes with 1.3 million detachable warrants (reference price of $13 million) and 10% OID to be funded over multiple tranches at 10% interest; •1 sttranche $3 million of funding at the Closing of the Merger, less OID; •2 ndtranche $3 million, upon registration of the underlying securities; •3 rdtranche $10 million, subject to trading conditions and subject to investment committee approval; and •4 thtranche $10 million, subject to trading conditions and subject to investment committee approval. Atalaya, Profusa and NorthView proceed with due diligence and drafting definitive agreements however, the parties could not finalize